Seoul, South Korea

Wahn Soo Choi

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.9

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1998-2015

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Wahn Soo Choi: Innovator in Pharmaceutical Composition

Introduction

Wahn Soo Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment and prevention of inflammatory diseases. With a total of 5 patents, his work has garnered attention for its innovative approaches to healthcare.

Latest Patents

Wahn Soo Choi's latest patents include a pharmaceutical composition that utilizes an ethyl acetate fraction of dried extract as an active ingredient. This composition is designed for treating and preventing inflammatory diseases. The extract is refined to contain a specific percentage of arctigenin, which serves as an index material. Another notable patent involves a mixture of herbal extracts that exhibit superior therapeutic effects for treating pains and acute inflammation, making it useful in the prevention and treatment of conditions such as arthritis.

Career Highlights

Throughout his career, Wahn Soo Choi has worked with reputable companies, including Yungjin Pharmaceutical Co., Ltd. and Sinil Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical solutions.

Collaborations

Wahn Soo Choi has collaborated with several professionals in his field, including Kae Jong Chung and Man Sik Chang. These collaborations have likely enhanced the quality and impact of his inventions.

Conclusion

Wahn Soo Choi's innovative work in pharmaceutical compositions demonstrates his commitment to advancing healthcare solutions. His patents reflect a deep understanding of the complexities of inflammatory diseases and the potential of herbal extracts in treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…